Expansion of polyglutamine stretches in several proteins causes neurodegenerative amyloidoses, including Huntington disease. In yeast, mutant huntingtin (mHtt) with a stretch of 103 glutamine residues (HttQ103) forms toxic aggregates. A range of yeast strains have been used to elucidate the mechanisms of mHtt toxicity, and have revealed perturbations of various unrelated processes. HttQ103 aggregates can induce aggregation of cellular proteins, many of which contain glutamine/asparagine-rich regions, including Sup35 and Def1. In the strain 74-D694 HttQ103, toxicity is related to aggregation-mediated depletion of soluble Sup35 and its interacting partner Sup45. Def1 was also implicated in mHtt toxicity, since its lack detoxified HttQ103 in another yeast strain, BY4741. Here we show that in BY4742, deletion of DEF1 lowers HttQ103 toxicity and decreases the amount of its polymers, but does not affect copolymerization of Sup35. Furthermore, in contrast to 74-D694, increasing the levels of soluble Sup35 and Sup45 does not alleviate toxicity of HttQ103 in BY4742. These data demonstrate a difference in the mechanisms underlying mHtt toxicity in different yeast strains and suggest that in humans with Huntington disease, neurons of different brain compartments and cells in other tissues can also be damaged by different mechanisms.
INTRODUCTION
Expansion of polyglutamine (polyQ) stretches in nine unrelated human proteins causes neurodegenerative diseases accompanied by deposition of amyloid aggregates, which these proteins form. One of the most common polyQ disorders, Huntington disease (HD), is caused by mutations that increase the number of CAG triplets in the first exon of the HTT gene encoding the huntingtin protein. The toxic effect of mutant huntingtin (mHtt) is related to its interference with the normal function of various proteins, which affects a wide variety of cellular processes (for a review, see Takahashi, Katada and Onodera 2010) . However, despite extensive studies, the mechanisms responsible for the above defects in HD are still far from clear.
Several genetically tractable eukaryotic experimental models have been established to elaborate the reasons of mHtt toxicity on molecular and cellular levels (Davies et al. 1999; Faber et al. 2002; Meriin et al. 2002; Landles et al. 2010; Weiss et al. 2012) . Among them, the simplest one is based on the use of Saccharomyces cerevisiae. As in animals, aggregation and toxicity of Htt in yeast increases with polyQ length. Targeting of mHtt into the cell nuclei alters transcription of a subset of genes and decreases viability of yeast cells (Hughes et al. 2001; Schaffar et al. 2004) . Meriin et al. (2003 Meriin et al. ( , 2007 ; Yang et al. (2016) 
BY4741 EY0986
Cell divisions Kaiser et al. (2013) 
BY4741
Tryptophan catabolism related to generation of reactive oxygen species Giorgini et al. (2005) W303 Endoplasmic reticulum-associated protein degradation Duennwald and Lindquist (2008) Only the main strains used to elucidate reasons of mHtt toxicity are listed. All the strains, except for 74-D694 and GT81, which are derivatives of 74-D694, are closely related to S288C. 74-D694 was obtained from a cross between a strain from the Peterhof genetic collection and a derivative of S288C (Drozdova et al. 2016) .
Cytotoxicity and aggregation of cytoplasmically expressed mHtt was shown to depend on the presence of [ et al. 2002) , the prion form of two glutamine/asparagine (Q/N)-rich proteins of which the first is the translation termination factor Sup35/eRF3, and the second is the Rnq1 protein with unknown function, which being in prion form facilitates the de novo appearance of other yeast prions (Sondheimer and Lindquist 2000; Derkatch et al. 2001) . Aggregation of mHtt in the cytoplasm of yeast cells alters endocytosis, tryptophan metabolism, translation, cell cycle progression, endoplasmic reticulum-associated protein degradation and functioning of mitochondria (Meriin et al. 2007; Bocharova et al. 2008; Duennwald and Lindquist 2008; Tauber et al. 2011; Kochneva-Pervukhova, Alexandrov and TerAvanesyan 2012; Papsdorf et al. 2015) . The molecular bases of these defects are largely unknown, though it was reported that mHtt induces polymerization of cellular proteins, many of which contain Q/N-rich regions (Urakov et al. 2010; Kryndushkin et al. 2013; Nizhnikov et al. 2014) . Among them, aggregation of the essential Sup35 protein was shown to represent a significant reason of mHtt toxicity (Kochneva-Pervukhova, Alexandrov and Ter-Avanesyan 2012; Zhao et al. 2012; Alexandrov et al. 2016) . Nonetheless, studies in yeast performed in different laboratories revealed numerous other reasons for mHtt toxicity with no apparent relation to aggregation of Sup35 (Table 1 ). The data on the reasons for mHtt toxicity in yeast are difficult to unify, since it is unclear whether mHtt effects are based on a single mechanism with different downstream manifestations, or if there are several independent pathological effects. The latter possibility could mean that different yeast strains could vary in their response to the various pathological effects of mHtt.
Here we demonstrated that yeast strains may indeed exhibit distinct mechanisms of mHtt cytotoxicity. While mHtt toxicity in the 74D-694 strain which we used in our previous studies is strongly dependent on the aggregation-related depletion of the soluble form of Sup35 accompanied with depletion of its interacting partner, translation termination factor Sup45/eRF1, aggregation of these proteins is not responsible for mHtt toxicity in the strain BY4742. The obtained data show strain specificity of the mechanisms of mHtt toxicity in yeast and also suggest that such differences may underlie differential vulnerability of various cell populations demonstrated in individuals with HD (for a review, see Han et al. 2010) .
MATERIALS AND METHODS

Plasmids, strains and growth conditions
The plasmids used in this study are described in Serpionov et al. (2015) . We used following yeast strains: 74-D694 To induce the synthesis of Htt25Q-/103Q-GFP or -RFP chimeric proteins, transformants with corresponding plasmids were incubated in liquid selective media with 2% raffinose as a sole carbon source to mid-log phase and then transferred to media with 2% galactose instead of raffinose and cells were grown for 11 h. For induction of these fusion proteins on solid media, cell suspensions incubated in raffinose-containing media were spotted onto plates containing selective media with 2% galactose as a sole carbon source. All growth assays were done in triplicate.
Measurement of fluorescence intensity
Cell suspensions grown as described above in liquid medium were equalized to an OD 600 of 0.5. RFP fluorescence (excitation: 555 nm, emission: 600 nm) was measured using a Multimode Plate Reader EnSpire (PerkinElmer, Waltham, MA, USA). Three independent cultures were measured for each strain.
Preparation of yeast cell lysates
Yeast cultures grown in liquid selective media were harvested, washed in water and lyzed by beating with glass beads in buffer A: 30 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM dithiothreitol. To prevent proteolytic degradation, the buffer was supplemented with 10 mM phenylmethylsulfonyl fluoride and Complete protease inhibitor cocktail (Roche Applied Science, Penzberg, Germany). Cell debris was removed by centrifugation at 1500 g for 4 min.
Electrophoresis and blotting
SDS-PAGE was performed according to the standard protocol in 10% polyacrylamide and SDD-AGE according to Kryndushkin et al. (2003) with some modifications . Protein loads were equalized for each gel. Proteins were were visualized by the use of anti-FLAG (AbFLAG) and anti-Sup35NM (AbSup35) antibodies; (C) SDS-PAGE analysis of Sup35 monomers. Lysates were obtained from cells grown as described above. The samples were not boiled before loading onto the gel which only allowed SDS-soluble Sup35 to enter the gel (Kushnirov et al. 2006; Kryndushkin et al. 2013) . The strain with the non-aggregating HttQ25 is presented as a control. Total lysates and 3-fold dilutions are presented. Blots were stained with anti-Sup35NM antibody. Lower bands represent a Sup35 degradation product, characteristic of the non-amyloid form of Sup35 (Paushkin et al. 1996) .
transferred from gels to nitrocellulose membranes sheets (Macherey-Nagel, Duren, Germany) by 5 h vacuum-assisted capillary blotting (agarose gels) or using the Biorad electroblotting system (polyacrylamide gels). Rabbit polyclonal antibodies against GFP (Santa-Cruz, Dallas, TX, USA), the N-terminal region of Sup35 (Sup35NM) and monoclonal antibody against the FLAG epitope (Sigma, St. Louis, MO, USA) were used. Bound antibody was detected using the ECL West Dura substrate (Thermo Scientific, Waltham, MA, USA). All electrophoresis experiments were repeated at least three times.
RESULTS
Deletion of DEF1 in BY4742 decreases the level of polymerized HttQ103 and alleviates its cytotoxicity, but does not affect polymerization of Sup35
The yeast model of HD is based on cells that express the first exon of the human HTT gene, encoding an expanded polyQ stretch (usually with 103 glutamine residues, Htt103Q). This protein aggregates and strongly inhibits yeast growth, thus mimicking toxicity. The same protein with a stretch of 25 glutamines (Htt25Q) is commonly used as a control, because it does not aggregate and is not toxic. To facilitate immunological and microscopic detection of the proteins, a FLAG epitope tags the Nterminus of the Htt proteins, while GFP or RFP is fused to the C-terminus (Meriin et al. 2002 (Meriin et al. , 2007 . Based on colocalization data of Duennwald et al. (2006) , we observed that in the BY4741 strain aggregates of HttQ103-RFP seed polymerization of Sup35 and three other Q/N-rich proteins, Yir003w, Ylr278c and Def1, Cterminally fused with GFP (data not shown). Besides, wild-type Def1 was also shown to form polymers upon HttQ103-GFP overproduction in 74-D694 (Nizhnikov et al. 2014) . Although it was reported that deletion of genes encoding these proteins alleviates toxicity of HttQ103 in BY4741 (Giorgini et al. 2005) , we reproduced this effect in BY4742 only for the DEF1 deletion (Fig. 1A) . Previously, we have shown that in 74-D694 a considerable source of Htt103Q-GFP cytotoxicity is depletion of a soluble form of the essential translation termination factor Sup35 due to seeding its polymerization (Kochneva-Pervukhova, Alexandrov and TerAvanesyan 2012) . This allowed us to hypothesize that detoxification of HttQ103-RFP by DEF1 deletion in BY4742 could also be due to a decreased ability of HttQ103-RFP polymers to seed polymerization of Sup35. However, examination of this suggestion showed that lack of Def1 significantly decreased the levels of HttQ103-RFP polymers, but did not noticeably affect either the amount of SDS-resistant complexes of Sup35 or the amount of SDS-soluble protein (Fig. 1B) . The decreased level of HttQ103-RFP polymers could be due to a decreased amount of the HttQ103-RFP protein, since DEF1 deletion decreased intensity of RFP fluorescence in Htt103-RFP bearing cells (Fig. 2) . Most likely this was due to inhibition of HttQ103-RFP expression, since deletion of DEF1 also decreased the levels of non-aggregating HttQ25-RFP, expression of which is governed by the same GAL1 promoter. This indicates that on its own Def1 is not involved in modulation of mHtt toxicity. Surprisingly, in contrast to BY4742, deletion of DEF1 in 74-D694 did not alleviate HttQ103-GFP toxicity, though it decreased its polymerization and the accompanying polymerization of Sup35 (Fig. 2) . Most probably, this was due to the inhibitory effect of DEF1 on yeast growth as seen by a decreased growth rate of the transformant expressing non-toxic HttQ25-GFP (Fig. 3) .
Depletion of Sup35 and Sup45 does not contribute to HttQ103 toxicity in the BY4742 strain
Toxicity of HttQ103-GFP in 74-D694 is related not only to aggregation-mediated depletion of Sup35 but also to a depletion of its partner protein, translation termination factor Sup45, which is sequestrated through binding to Sup35 polymers. This was proved by expressing of the non-aggregating form of Sup35, which lacked the NM region (Sup35C), instead of the full-length protein and overproduction of Sup45, both of which alleviated the toxic effect of HttQ103-GFP (Kochneva-Pervukhova, Alexandrov and Ter-Avanesyan 2012). However, as was shown above, deletion of DEF1 in BY4742 alleviates HttQ103-RFP toxicity, but does not decrease polymerization of Sup35, thus suggesting that decreased levels of soluble translation termination factors is not an ubiquitous cause of HttQ103 toxicity in yeast. To confirm this, we examined whether simultaneous overproduction of Sup35C and Sup45 abrogated the toxic effect of HttQ103-RFP in BY4742. Strikingly, it again appeared that this strain differs from 74-D694, because toxicity of HttQ103-RFP in BY4742 was not mitigated by an excess of Sup35C and Sup45 (Fig. 4) .
DISCUSSION
Earlier three groups independently reported that toxicity of HttQ103 is related to aggregation-mediated depletion of Sup35 and/or depletion of its interacting partner, Sup45 (Gong et al. 2012; Kochneva-Pervukhova, Alexandrov and Ter-Avanesyan 2012; Zhao et al. 2012) . Of note, this was shown using the 74-D694 strain and its closely related derivative GT81. In contrast, here we showed that even though HttQ103 polymers in BY4742 induce polymerization of Sup35, this is not the cause of growth inhibition. The reason for the difference in response of these strains to Sup35 depletion may lie in different requirements of these strains for activity of termination factors, i.e. BY4742 may possess genetic modifiers able to compensate deficiency of these factors. This possibility is supported by the observations that repression of Sup35 or Sup45 expression up to 10-fold causes significant cell mortality (Valouev, Kushnirov and TerAvanesyan 2002) , while there are mutants with extremely low levels of Sup35 and Sup45 proteins (Chabelskaya et al. 2004; Kiktev et al. 2009) . It is likely, though this was never examined, that such mutant strains can survive due to coappearance of mutations compensating the shortage of translation termination factors. By their origin, 74-D694 and GT81 differ from other yeast stains used to study mHtt toxicity. While most such strains are related to the S288C prototype, 74-D694 was obtained from a cross between a S288C-related strain and a strain from the Peterhof genetic collection, which derived from an independent yeast isolate (Drozdova et al. 2016) . Thus, since in BY4742 crossseeding of Sup35 polymerization by HttQ103 is not harmful, growth inhibition of this strain could result from other deleterious effects of HttQ103 polymers (Table 1) , which may also play some role in 74-D694, since depletion of Sup35 and Sup45 is not the sole source of HttQ103 toxicity in this strain (KochnevaPervukhova, Alexandrov and Ter-Avanesyan 2012) . Both strains used in this work to model mHtt toxicity contain [PIN + ], a prion form of the Rnq1 protein, which significantly enhances HttQ103 polymerization and toxicity (Kochneva-Pervukhova, Alexandrov and Ter-Avanesyan 2012) . However, here we demonstrated that polymerization of HttQ103 also depends on the Def1 protein, which is able to copolymerize with HttQ103 in both BY4742 and 74-D694. However, in contrast to 74-D694, decreased level of HttQ103 polymers in BY4742 with deleted DEF1 is not accompanied by a decrease of amount of Sup35 polymers, and therefore HttQ103 polymers in this strain are more efficient in cross-seeding Sup35 polymerization than in the parent strain with wild-type DEF1. Thus, we reveal that Def1 interferes with copolymerization of Sup35, though this effect was observed only in the BY4742 strain. The negative role of Def1 in seeding Sup35 polymerization by HttQ103 can be explained by competition between the Def1 and Sup35 monomers for the binding to HttQ103 polymer seeds, though if this true, such competition takes place only in one of the two studied strains. The data obtained in this work demonstrate that Saccharomyces cerevisiae strains can differ from each other by the mechanisms causing mHtt toxicity. This suggests that despite ubiquitous mHtt expression in human tissues, aggregation of this protein can cause toxicity via distinct mechanisms in different cell types.
